Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia
Jeffrey L Carson,Maria Mori Brooks,Paul C Hébert,Shaun G Goodman,Marnie Bertolet,Simone A Glynn,Bernard R Chaitman,Tabassome Simon,Renato D Lopes,Andrew M Goldsweig,Andrew P DeFilippis,J Dawn Abbott,Brian J Potter,Francois Martin Carrier,Sunil V Rao,Howard A Cooper,Shahab Ghafghazi,Dean A Fergusson,William J Kostis,Helaine Noveck,Sarang Kim,Meechai Tessalee,Gregory Ducrocq,Pedro Gabriel Melo de Barros E Silva,Darrell J Triulzi,Caroline Alsweiler,Mark A Menegus,John D Neary,Lynn Uhl,Jordan B Strom,Christopher B Fordyce,Emile Ferrari,Johanne Silvain,Frances O Wood,Benoit Daneault,Tamar S Polonsky,Manohara Senaratne,Etienne Puymirat,Claire Bouleti,Benoit Lattuca,Harvey D White,Sheryl F Kelsey,P Gabriel Steg,John H Alexander,MINT Investigators
DOI: https://doi.org/10.1056/NEJMoa2307983
2023-12-28
Abstract:Background: A strategy of administering a transfusion only when the hemoglobin level falls below 7 or 8 g per deciliter has been widely adopted. However, patients with acute myocardial infarction may benefit from a higher hemoglobin level. Methods: In this phase 3, interventional trial, we randomly assigned patients with myocardial infarction and a hemoglobin level of less than 10 g per deciliter to a restrictive transfusion strategy (hemoglobin cutoff for transfusion, 7 or 8 g per deciliter) or a liberal transfusion strategy (hemoglobin cutoff, <10 g per deciliter). The primary outcome was a composite of myocardial infarction or death at 30 days. Results: A total of 3504 patients were included in the primary analysis. The mean (±SD) number of red-cell units that were transfused was 0.7±1.6 in the restrictive-strategy group and 2.5±2.3 in the liberal-strategy group. The mean hemoglobin level was 1.3 to 1.6 g per deciliter lower in the restrictive-strategy group than in the liberal-strategy group on days 1 to 3 after randomization. A primary-outcome event occurred in 295 of 1749 patients (16.9%) in the restrictive-strategy group and in 255 of 1755 patients (14.5%) in the liberal-strategy group (risk ratio modeled with multiple imputation for incomplete follow-up, 1.15; 95% confidence interval [CI], 0.99 to 1.34; P = 0.07). Death occurred in 9.9% of the patients with the restrictive strategy and in 8.3% of the patients with the liberal strategy (risk ratio, 1.19; 95% CI, 0.96 to 1.47); myocardial infarction occurred in 8.5% and 7.2% of the patients, respectively (risk ratio, 1.19; 95% CI, 0.94 to 1.49). Conclusions: In patients with acute myocardial infarction and anemia, a liberal transfusion strategy did not significantly reduce the risk of recurrent myocardial infarction or death at 30 days. However, potential harms of a restrictive transfusion strategy cannot be excluded. (Funded by the National Heart, Lung, and Blood Institute and others; MINT ClinicalTrials.gov number, NCT02981407.).